Repligen Corporation
TimesSquare owns Repligen for its role as a supplier of essential reagents and precursors used to manufacture biological medicines, sometimes as the sole source. The announced…
TimesSquare Capital Management, LLC is a registered investment adviser managing growth-equity portfolios. Its Global Small Cap strategy seeks quality businesses across developed markets through company-level research and a diversified portfolio of approximately 110 stocks. The composite began on January 1, 2018.
TimesSquare owns Repligen for its role as a supplier of essential reagents and precursors used to manufacture biological medicines, sometimes as the sole source. The announced…
TimesSquare initiated Construction Partners after meeting management and identifying benefits from consolidation and vertical integration. The business builds and maintains…
TimesSquare established a new position in Eastern Bankshares, a New England regional bank. The central part of the thesis is significant excess capital that can finance elevated…
TimesSquare added to Fukuoka Financial throughout the quarter as Japan moved into a higher interest-rate environment. Earnings exceeded expectations and profits rose 27% year…
TimesSquare viewed Victory Capital’s continuing net inflows and proposed acquisition of First Eagle Investments favorably. The asset manager’s autonomous investment boutiques use…
TimesSquare modestly added back to Regal Rexnord after concluding that the stock’s sharp decline was overly punitive. The company provides motion control, climate solutions and…
TimesSquare added to Valvoline after an earnings-driven share-price pullback, believing the disruption to margins from oil-related input costs is temporary. Comparable sales grew…
TimesSquare added to MYR Group despite a sharp share-price decline driven by fears of political opposition to U.S. data-center construction. The company builds electric utility…
Source PDFs are not republished here; only extracted ideas and quotes.